300451.SHE B-Soft Co Ltd
- Market cap
- CNY 5.34B
- P/E
- -
- P/B
- 1.35x
- ROE
- -11.2%
- Dividend yield
- 0.01%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300451.SHE undervalued?
Graham numberThe Graham number of B-Soft Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
B-Soft Co Ltd fundamental analysis
No fundamental analysis for B-Soft Co Ltd yet.
B-Soft Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About B-Soft Co Ltd
B-SOFT Co.,Ltd. operates in the healthcare information technology industry in China. The company offers Huikang·Yunshu Intelligent Body, a medical AI agent of Huikang. It also provides outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and hospital cloud platform; and big data and artificial intelligence, hospital-wide medical-technical integration, mobile intelligent healthcare, hospital multidisciplinar…
Full company profileB-Soft Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
B-Soft Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 549M | 1.15B | 1.29B | 1.48B | 1.63B | 1.90B | 1.53B | 1.62B | 1.42B | 1.05B | 918M |
| Gross Profit | 269M | 564M | 642M | 790M | 904M | 1.03B | 752M | 754M | 617M | 375M | 303M |
| Operating Income | 38.6M | 201M | 247M | 357M | 378M | 452M | 52.9M | 43.7M | -163M | -179M | -317M |
| EBITDA | 37.9M | 207M | 269M | 338M | 407M | 466M | 209M | 141M | -106M | -237M | -414M |
| Net Income | 63.0M | 163M | 213M | 314M | 332M | 413M | 42.6M | 36.7M | -174M | -402M | -415M |
| EPS | 0.05 | 0.12 | 0.15 | 0.22 | 0.22 | 0.27 | 0.03 | 0.02 | -0.11 | -0.26 | -0.27 |
| Balance Sheet | |||||||||||
| Total Assets | 1.13B | 2.70B | 3.08B | 3.59B | 5.25B | 5.61B | 5.78B | 5.79B | 5.67B | 5.28B | 5.01B |
| Total Liabilities | 377M | 627M | 721M | 964M | 1.07B | 1.01B | 1.18B | 1.13B | 1.19B | 1.20B | 1.24B |
| Shareholders' Equity | 725M | 2.04B | 2.32B | 2.59B | 4.14B | 4.56B | 4.59B | 4.61B | 4.42B | 4.01B | 3.71B |
| Cash & Short-term Investments | 318M | 361M | 468M | 534M | 1.77B | 1.62B | 1.48B | 1.11B | 1.03B | 455M | 339M |
| Total Debt | 6.00M | 100M | 178M | 203M | 163M | 13.7M | 107M | 16.2M | 56.6M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 119M | 174M | 170M | 80.2M | 271M | 176M | 145M | 158M | 115M | -21.2M | - |
| Capital Expenditure | 114M | 49.4M | 112M | 120M | 205M | 191M | 320M | 392M | 243M | 172M | 77.4M |
| Free Cash Flow | 4.55M | 125M | 58.0M | -40.0M | 66.2M | -14.4M | -175M | -234M | -128M | -194M | -768M |
| Ratios | |||||||||||
| ROE | 8.7% | 8.0% | 9.2% | 12.1% | 8.0% | 9.1% | 0.9% | 0.8% | -3.9% | -10.0% | -11.2% |
| ROA | 5.6% | 6.0% | 6.9% | 8.7% | 6.3% | 7.4% | 0.7% | 0.6% | -3.1% | -7.6% | -8.3% |
| Net Profit Margin | 11.5% | 14.2% | 16.5% | 21.2% | 20.4% | 21.8% | 2.8% | 2.3% | -12.2% | -38.2% | -45.2% |
| Debt to Equity | 0.01x | 0.05x | 0.08x | 0.08x | 0.04x | 0.00x | 0.02x | 0.00x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
B-Soft Co Ltd dividends
- Dividend yield
- 0.01%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 31, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 345K | 0.00 | - |
| 2024 | CNY 16.0M | 0.01 | - |
| 2023 | CNY 15.5M | 0.01 | 42.2% |
| 2022 | CNY 46.5M | 0.03 | 109.1% |
| 2021 | CNY 35.8M | 0.02 | 8.7% |
| 2020 | CNY 33.2M | 0.02 | 10.0% |
| 2019 | CNY 24.3M | 0.02 | 7.7% |
| 2018 | CNY 34.6M | 0.02 | 16.3% |
| 2017 | CNY 27.3M | 0.02 | 16.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jun 28, 2021.
Who owns B-Soft Co Ltd
- Insiders 25.04%
- Institutions 5.59%
- Public & others 69.37%
- Shares outstanding 1.55B
- Free float 1.38B
B-Soft Co Ltd company profile
- Company name
- B-Soft Co Ltd
- Ticker
- 300451.SHE
- ISIN
- CNE100001ZG7
- Exchange
- Shenzhen Stock Exchange
- Listed since
- May 7, 2015
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 3,731
- Fiscal year end
- December
- Address
- No. 708 Jianta Street, Hangzhou, China, 310053
- Phone
- 86 571 8821 7878
- Website
- bsoft.com.cn
About B-Soft Co Ltd
B-SOFT Co.,Ltd. operates in the healthcare information technology industry in China. The company offers Huikang·Yunshu Intelligent Body, a medical AI agent of Huikang. It also provides outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and hospital cloud platform; and big data and artificial intelligence, hospital-wide medical-technical integration, mobile intelligent healthcare, hospital multidisciplinary consultation, clinical decision, b-soft overall solution for epidemic prevention and control, and Hi-HIS. In addition, the company offers management decision support, intelligent comprehensive management, hospital medical insurance risk management, performance management, intelligent management application, refined management system for low value consumables, consumables traceability management system, and consumables trading supervision and drug trade supervision platform; and intelligent IoT, multidisciplinary telemedicine, and 5G prehospital emergency. Further, it provides medical security information platform, DRG/DIP hospital side applications, and single disease quality management control; intelligent health; and city level health services platform and internet plus nursing services. B-SOFT Co.,Ltd. was founded in 1997 and is headquartered in Hangzhou, China.
B-Soft Co Ltd management
4- Mr. Zhongyang ChenGM & Employee Representative Director · born 1979
- Ms. Yan HuBoard Secretary & Deputy General Manager · born 1977
- Mr. Xiaoyi YuDeputy General Manager · born 1980
- Mr. Wenhao MaHead of Accounting · born 1973